Investor's Business Daily on MSN18m
GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 BillionGSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback